KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Cash from Financing Activities (2018 - 2025)

Historic Cash from Financing Activities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$13.4 million.

  • BioNTech SE's Cash from Financing Activities fell 5495.89% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.8 million, marking a year-over-year increase of 875.2%. This contributed to the annual value of -$49.0 million for FY2024, which is 9414.5% up from last year.
  • Latest data reveals that BioNTech SE reported Cash from Financing Activities of -$13.4 million as of Q3 2025, which was down 5495.89% from -$15.1 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Cash from Financing Activities ranged from a high of $184.1 million in Q2 2021 and a low of -$833.9 million during Q2 2022
  • Its 5-year average for Cash from Financing Activities is -$117.2 million, with a median of -$13.9 million in 2023.
  • Examining YoY changes over the last 5 years, BioNTech SE's Cash from Financing Activities showed a top increase of 166032932213.35% in 2022 and a maximum decrease of 11800113597.83% in 2022.
  • BioNTech SE's Cash from Financing Activities (Quarter) stood at $55.94 in 2021, then crashed by 118001135.98% to -$66.0 million in 2022, then skyrocketed by 78.97% to -$13.9 million in 2023, then skyrocketed by 43.8% to -$7.8 million in 2024, then crashed by 72.34% to -$13.4 million in 2025.
  • Its last three reported values are -$13.4 million in Q3 2025, -$15.1 million for Q2 2025, and -$14.5 million during Q1 2025.